Strain Differences Separate Helpful and Harmful Elements of the Human Microbiome
|
By LabMedica International staff writers Posted on 12 Mar 2013 |
A recent microbiome study demonstrated the importance of evaluating bacteria at the strain rather than the genus or species level in order to understand their contribution to human health or disease.
Investigators at the University of California, Los Angeles (USA) and collaborators at Washington University (St. Louis, MO, USA) and the Los Angeles Biomedical Research Institute (CA, USA) selected the skin disorder acne as a model to explore the relationship between the causative organism Propionibacterium acnes and the human immune system, which generates the inflammatory response that causes the characteristic pimples, redness, and blotchy skin.
The investigators compared the skin microbiome at the strain level and genome level of P. acnes between 49 acne patients and 52 healthy individuals by sampling the sebaceous units on their noses. More than 1,000 strains of the bacteria were cultured from the isolates, and the genomes of 66 of the P. acnes strains were sequenced.
Metagenomic analysis published in the February 28, 2013, online edition of the Journal of Investigative Dermatology demonstrated that although the relative abundances of P. acnes were similar, the strain population structures were significantly different in the two cohorts. Certain strains were highly associated with acne, and other strains were enriched in healthy skin.
By sequencing 66 previously unreported P. acnes strains and comparing 71 P. acnes genomes, the investigators identified potential genetic determinants of various P. acnes strains in association with acne or health. The analysis suggested that acquired DNA sequences and bacterial immune elements may have roles in determining virulence properties of P. acnes strains, and some could be future targets for therapeutic interventions. Furthermore, the results underscored the importance of strain-level analysis of the human microbiome to define the role of the microbial flora in health and disease.
"We learned that not all acne bacteria trigger pimples—one strain may actually help keep skin healthy," said senior author Dr. Huiying Li, assistant professor of molecular and medical pharmacology at the University of California, Los Angeles. "We hope to apply our findings to develop new strategies that stop blemishes before they start, and enable dermatologists to customize treatment to each patient's unique cocktail of skin bacteria."
"We were extremely excited to uncover a third strain of P. acnes that is common in healthy skin yet rarely found when acne is present," said Dr. Li. "We suspect that this strain contains a natural defense mechanism that enables it to recognize attackers and destroy them before they infect the bacterial cell. This P. acnes strain may protect the skin, much like yogurt's live bacteria help defend the gut from harmful bugs. Our next step will be to investigate whether a probiotic cream can block bad bacteria from invading the skin and prevent pimples before they start."
Related Links:
University of California, Los Angeles
Washington University
Los Angeles Biomedical Research Institute
Investigators at the University of California, Los Angeles (USA) and collaborators at Washington University (St. Louis, MO, USA) and the Los Angeles Biomedical Research Institute (CA, USA) selected the skin disorder acne as a model to explore the relationship between the causative organism Propionibacterium acnes and the human immune system, which generates the inflammatory response that causes the characteristic pimples, redness, and blotchy skin.
The investigators compared the skin microbiome at the strain level and genome level of P. acnes between 49 acne patients and 52 healthy individuals by sampling the sebaceous units on their noses. More than 1,000 strains of the bacteria were cultured from the isolates, and the genomes of 66 of the P. acnes strains were sequenced.
Metagenomic analysis published in the February 28, 2013, online edition of the Journal of Investigative Dermatology demonstrated that although the relative abundances of P. acnes were similar, the strain population structures were significantly different in the two cohorts. Certain strains were highly associated with acne, and other strains were enriched in healthy skin.
By sequencing 66 previously unreported P. acnes strains and comparing 71 P. acnes genomes, the investigators identified potential genetic determinants of various P. acnes strains in association with acne or health. The analysis suggested that acquired DNA sequences and bacterial immune elements may have roles in determining virulence properties of P. acnes strains, and some could be future targets for therapeutic interventions. Furthermore, the results underscored the importance of strain-level analysis of the human microbiome to define the role of the microbial flora in health and disease.
"We learned that not all acne bacteria trigger pimples—one strain may actually help keep skin healthy," said senior author Dr. Huiying Li, assistant professor of molecular and medical pharmacology at the University of California, Los Angeles. "We hope to apply our findings to develop new strategies that stop blemishes before they start, and enable dermatologists to customize treatment to each patient's unique cocktail of skin bacteria."
"We were extremely excited to uncover a third strain of P. acnes that is common in healthy skin yet rarely found when acne is present," said Dr. Li. "We suspect that this strain contains a natural defense mechanism that enables it to recognize attackers and destroy them before they infect the bacterial cell. This P. acnes strain may protect the skin, much like yogurt's live bacteria help defend the gut from harmful bugs. Our next step will be to investigate whether a probiotic cream can block bad bacteria from invading the skin and prevent pimples before they start."
Related Links:
University of California, Los Angeles
Washington University
Los Angeles Biomedical Research Institute
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Blood Test Guides More Effective Ovarian Cancer Treatment
Ovarian cancer affects hundreds of thousands of women worldwide each year, yet only some respond to PARP inhibitor therapy, which targets tumors with defective DNA repair. Clinicians have long observed... Read more
Liquid Biopsy Test to Enable Earlier Diagnosis of Numerous Cancer Types
Routine screening currently covers only a handful of cancers, leaving most cases detected after symptoms appear—often at advanced stages when outcomes are poorer. A new study now suggests that adding a... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read moreMicrobiology
view channel
Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis
Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
Distinguishing minor childhood illnesses from potentially life-threatening infections such as sepsis or meningitis remains a major challenge in emergency care. Traditional tests can take hours, leaving... Read more
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read morePathology
view channel
Unique Immune Signatures Distinguish Rare Autoimmune Condition from Multiple Sclerosis
Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) is a rare autoimmune disorder in which the immune system attacks the myelin sheath in the central nervous system. Although symptoms... Read more
Simple Optical Microscopy Method Reveals Hidden Structures in Remarkable Detail
Understanding how microscopic fibers are organized in human tissues is key to revealing how organs function and how diseases disrupt them. However, these fiber networks have remained difficult to visualize... Read moreTechnology
view channel
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read more
AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
Detecting lung cancer early remains one of the biggest challenges in oncology, largely because current tools are invasive, expensive, or unable to identify the disease in its earliest phases.... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more







 Analyzer.jpg)
